ASX/CSL (ASX/CSL)

Australian Securities Exchange: ASX/CSL · AUD

A$198

+0.39 (+0.2%)· Recorded snapshot

Market cap	94.6B
Revenue (ttm)	22.8B
Net income (ttm)	-3.7B
EPS (ttm)	-A$7.73
Shares out	478.9M
P/E (forward)	22.5x
Dividend	A$4.15 (2.10%)
Volume	896,782
Beta	0.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 22.8B
Net income (ttm): -3.7B
EPS (ttm): -A$7.73
P/E (forward): 22.5x
Market cap: 94.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E22.5

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-15.8

P25 n/aP50 n/aP75 n/a

ROIC16.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/CSL indicators

Market & fundamental data

Available fields

248

Groups with data

Currency

USD

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2027-02-10
Employees	29,000
Employees change	-904
Employees growth	-3.02%
Enterprise value	AUD 110.3B
Exchange	Australian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1916
In index	ASX200
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000CSL8
Last earnings date	2026-08-18
Last refreshed	2026-10-29
Last stock split date	2007-10-18
Last stock split type	Forward
Market cap	AUD 94.6B
Next earnings date	2027-02-10
Price	AUD 197.50
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/CSL
Website	https://www.csl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	21.59x
Average P/E ratio (10Y)	36.24x
Average P/E ratio (3Y)	32.97x
Average P/E ratio (5Y)	36.96x
Earnings yield	-3.92%
EV/EBIT	18x
EV/EBITDA	14.75x
EV/FCF	26.63x
EV/Sales	4.83x
FCF / EV yield	3.75%
FCF yield	4.38%
Forward P/E	22.46x
Industry forward P/E	28.82x
P/(FCF - SBC) ratio	24.29x
P/(OCF - SBC) ratio	19.59x
P/B ratio	4.01x
P/FCF ratio	22.83x
P/OCF ratio	18.63x
P/S ratio	4.14x
PEG ratio	3.34x
Price / tangible book value	17.07x
Price/EBITDA ratio	12.89x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.85%
EBITDA margin	32.15%
FCF margin	18.44%
Gross margin	51.12%
Operating margin	26.85%
Pretax margin	-25.87%
Profit margin	-16.33%
Profit per employee	AUD -128,550
Revenue per employee	AUD 787,399
ROA	7.26%
ROA (5Y)	6.99%
ROCE	14.99%
ROE	-15.83%
ROE (5Y)	9.52%
ROIC	16.51%
ROIC (5Y)	13.78%
SBC / revenue	1.09%
Tax / revenue	-6.97%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	-2.02%
FCF growth (Q)	-9%
FCF growth (QoQ)	84.89%
FCF growth 3Y	27.8%
FCF growth 5Y	3.39%
Gross profit growth	-0.05%
Gross profit growth (Q)	2.35%
Gross profit growth 3Y	4.9%
Gross profit growth 5Y	6.68%
Net income growth years	0
OCF growth	-1.38%
OCF growth (Q)	-4%
OCF growth (QoQ)	69.74%
OCF growth 10Y	11.54%
OCF growth 3Y	10.53%
OCF growth 5Y	-0.61%
Operating income growth	3.34%
Operating income growth (Q)	16.15%
Operating income growth 3Y	7.41%
Operating income growth 5Y	6.26%
Revenue growth	1.54%
Revenue growth (Q)	5.51%
Revenue growth (QoQ)	-10.41%
Revenue growth 10Y	9.96%
Revenue growth 3Y	5.88%
Revenue growth 5Y	8.91%
Revenue growth quarters	3
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -933.8M
Depreciation and amortization	AUD 1.2B
EBIT	AUD 6.1B
EBITDA	AUD 7.3B
EPS	AUD -7.73
FCF per share	AUD 8.65
Financing cash flow	AUD -4.1B
Free cash flow	AUD 4.1B
Free cash flow minus SBC	AUD 3.9B
Gross profit	AUD 11.7B
Income taxes	AUD -1.6B
Investing cash flow	AUD -1.8B
Net borrowing	AUD -806.4M
Net cash flow	AUD -930.9M
Net income	AUD -3.7B
Operating cash flow minus SBC	AUD 4.8B
Operating income	AUD 6.1B
Revenue	AUD 22.8B
Stock-based compensation	AUD 248.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.66
Book value per share	AUD 44.66
Debt / EBITDA	2.11
Debt / equity	0.67
Debt / FCF	3.8
Goodwill	AUD 9.1B
Interest coverage	9.86
Long-term assets	AUD 31.8B
Long-term liabilities	AUD 17.4B
Net cash (debt)	AUD -13.6B
Net cash / market cap	-14.34%
Net debt / EBITDA	1.85
Net debt / equity	0.58
Net debt / FCF	3.27
Piotroski F-Score	5
Property, plant and equipment	AUD 11.7B
Shareholders' equity	AUD 23.6B
Tangible book value	AUD 5.5B
Tangible book value per share	AUD 11.57
Total assets	AUD 48.6B
Total cash	AUD 2.2B
Total debt	AUD 15.8B
Total liabilities	AUD 25.1B
WACC	4.47%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	AUD 16.8B
Current liabilities	AUD 7.6B
Current ratio	2.21
Inventory turnover	1.18
Net working capital	AUD 8.8B
Quick ratio	0.91
Working capital	AUD 9.4B
Working capital turnover	3.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.87%
Dividend growth	-10.36%
Dividend growth (10Y)	9.07%
Dividend growth (3Y)	3.75%
Dividend growth (5Y)	6.64%
Dividend growth years	4
Dividend payment date	2026-10-02
Dividend payment years	33
Dividend payout frequency	Semi-Annual
Dividend per share	AUD 4.15
Dividend yield	2.1%
Ex-dividend date	2026-09-09
FCF payout ratio	46.86%
Last dividend	AUD 2.24
Shareholder yield	2.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	98.85%
10Y return CAGR	8.64%
10Y total return	129.06%
150-day SMA	AUD 140.53
15Y price change	579.16%
15Y return CAGR	15.39%
15Y total return	756.42%
1D price change	0.2%
1M price change	8.57%
1M total return	8.57%
1W price change	0.69%
1W total return	0.69%
1Y price change	11.04%
1Y return CAGR	13.95%
1Y total return	13.94%
20-day SMA	AUD 188.86
200-day SMA	AUD 144.41
20Y price change	918.04%
20Y return CAGR	14.15%
20Y total return	1,311.51%
3M price change	65.24%
3M total return	67.39%
3Y price change	-15.63%
3Y return CAGR	-3.64%
3Y total return	-10.52%
50-day SMA	AUD 180.50
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 199.00
52-week high date	2026-10-28
52-week low	AUD 90.00
52-week low date	2026-06-03
5Y price change	-34.13%
5Y return CAGR	-6.47%
5Y total return	-28.42%
6M price change	53.22%
6M total return	55.21%
All-time high	AUD 342.75
All-time high date	2020-02-20
All-time low	AUD 0.77
All-time low date	1994-06-21
Average true range (ATR)	AUD 3.77
Average volume	1M
Beta (1Y)	0.45
Beta (2Y)	0.34
Beta (5Y)	0.08
Change from 52-week high	-0.75%
Change from 52-week low	119.44%
Change from all-time high	-42.38%
Change from all-time low	25,549.35%
Change from open	0.25%
Day's gap	-0.05%
Dollar volume	AUD 177.1M
High price	AUD 198.43
Low price	AUD 196.20
Monthly RSI	50.22
Open price	AUD 197.00
Position in 52-week range	58.3%
Previous close	AUD 197.10
Price vs 150-day SMA	40.54%
Price vs 20-day SMA	4.58%
Price vs 200-day SMA	36.76%
Price vs 50-day SMA	9.42%
Relative volume	0.9
RSI	74.55
Sharpe ratio	0.42
Sharpe ratio (3Y)	-0.15
Sharpe ratio (5Y)	-0.28
Sortino ratio	0.79
Sortino ratio (3Y)	-0.02
Sortino ratio (5Y)	-0.18
Volume	896.8K
Weekly RSI	72.98
YTD price change	14.39%
YTD total return	17.38%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	478.5M
Shares change (QoQ)	-1.18%
Shares change (YoY)	-0.87%
Shares held by insiders	0.08%
Shares held by institutions	40.27%
Shares outstanding	478.9M

Deeper analysis on ASX/CSL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/CSL report

Is a complete ASX/CSL research report available?

No complete published report is available for asx/CSL (ASX/CSL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/CSL (ASX/CSL)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/CSL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/CSL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/CSL

Frequently asked questions